Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recent Onset type1 Diabetes”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Not applicableStudy completedNCT03423862
What this trial is testing

Development of Predictive Biomarkers

Who this might be right for
Type1diabetes
Medical College of Wisconsin 50
Large-scale testing (Phase 3)Study completedNCT03875729
What this trial is testing

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

Who this might be right for
Type 1 Diabetes Mellitus
Provention Bio, Inc. 328
Not applicableEnded earlyNCT00870818
What this trial is testing

Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)

Who this might be right for
Type 1 Diabetes Mellitus
MacroGenics 219
Testing effectiveness (Phase 2)Ended earlyNCT04628481
What this trial is testing

Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Who this might be right for
Recent Onset type1 Diabetes
Dompé Farmaceutici S.p.A 289
Not applicableStudy completedNCT00212329
What this trial is testing

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100
Testing effectiveness (Phase 2)Study completedNCT04270942
What this trial is testing

At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)

Who this might be right for
Diabetes Mellitus, Type 1
Provention Bio, a Sanofi Company 6
Testing effectiveness (Phase 2)Ended earlyNCT04524949
What this trial is testing

IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

Who this might be right for
Diabetes Mellitus, Type 1
Imcyse SA 110
Not applicableActive Not RecruitingNCT04598893
What this trial is testing

Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)

Who this might be right for
Diabetes Mellitus, Type 1
Provention Bio, a Sanofi Company 188
Not applicableUnknownNCT03037190
What this trial is testing

Preservation of Residual Beta Cell Mass and Prevention of Celiac Disease in Children With Recent Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1RemissionCeliac Disease in Children
Lund University 160
Large-scale testing (Phase 3)Ended earlyNCT00920582
What this trial is testing

Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
MacroGenics 254
Testing effectiveness (Phase 2)Study completedNCT01785108
What this trial is testing

DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen

Who this might be right for
Diabetes Mellitus, Type 1
Johnny Ludvigsson 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07614412
What this trial is testing

SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.

Who this might be right for
Type 1 Diabetes Mellitus
Ministry of Health, Saudi Arabia 240
Testing effectiveness (Phase 2)Looking for participantsNCT07199946
What this trial is testing

A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil

Who this might be right for
Type 1 Diabetes
Johnny Ludvigsson 36
Early research (Phase 1)UnknownNCT02820558
What this trial is testing

Neuropeptide Therapy of Recent Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Vanilloid Genetics Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00505375
What this trial is testing

Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 112
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06938334
What this trial is testing

A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes

Who this might be right for
Diabetes, Type I
Altheia Science 15
Testing effectiveness (Phase 2)Study completedNCT02691247
What this trial is testing

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Who this might be right for
Diabetes Mellitus
Lisata Therapeutics, Inc. 113
Testing effectiveness (Phase 2)Study completedNCT00129259
What this trial is testing

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 83
Testing effectiveness (Phase 2)Looking for participantsNCT06783309
What this trial is testing

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Who this might be right for
Type 1 Diabetes MellitusT1DT1DM+7 more
COUR Pharmaceutical Development Company, Inc. 72
Large-scale testing (Phase 3)Not Yet RecruitingNCT07670650
What this trial is testing

PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study

Who this might be right for
Type 1 Diabetes (T1D)
University of Florida 108
Next Page